|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Kidney Stones | |||||
| Ureteral Stones | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Calculi | |||||
| Emergencies | |||||
| Kidney Calculi | |||||
| Ureteral Calculi | |||||
| Ureterolithiasis | |||||
| 3 | More general conditions related to this trial | ||||
| Disease Attributes | |||||
| Kidney Diseases | |||||
| Nephrolithiasis | |||||
| Pathologic Processes | |||||
| Pathological Conditions, Anatomical | |||||
| Ureteral Diseases | |||||
| Urinary Calculi | |||||
| Urolithiasis | |||||
| Urologic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Tamsulosin (Flomax) | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Tamsulosin | |||||
| 6 | More general drug interventions related to this trial | ||||
| Adrenergic Agents | |||||
| Adrenergic alpha-Antagonists | |||||
| Adrenergic Antagonists | |||||
| Antineoplastic Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Neurotransmitter Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| William Beaumont Hospitals | |||||